Charlotte Monique Huijts

DR.

20112019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial

Huijts, C. M., Lougheed, S. M., Bodalal, Z., van Herpen, C. M., Hamberg, P., Tascilar, M., Haanen, J. B., Verheul, H. M., de Gruijl, T. D., van der Vliet, H. J. & Dutch WIN-O Consortium, 13 Mar 2019, In : Cancer Immunology, Immunotherapy. 68, 3, p. 503-515

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma

Dutch WIN-O Consortium, 9 Nov 2018, In : Cancer Immunology, Immunotherapy.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Immunological effects of everolimus in patients with metastatic renal cell cancer

Huijts, C. M., Santegoets, S. J., de Jong, T. D., Verheul, H. M., de Gruijl, T. D. & van der Vliet, H. J., 1 Dec 2017, In : International Journal of Immunopathology and Pharmacology. 30, 4, p. 341-352 12 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access